Hyperspectral Drusen Classification

计划入组 112 人 · 首次发布于 2025 年 3 月 6 日

Sub-threshold Micro-Pulse Laser Therapy for Drusen of Dry AMD

计划入组 20 人 · 首次发布于 2019 年 5 月 30 日

Risk Factors for Drusen Progression

首次发布于 2013 年 4 月 12 日

familial hypercholesterolemia program

VRX-LDLR

LeXis gene therapy (familial hypercholesterolemia)

The Familial Hypercholesterolemia Foundation

United States

Madrigal Pharmaceuticals

United States

FUNDACION HIPERCOLESTEROLEMIA FAMILIAR

Spain

Sanaregen Vision Therapeutics Receives FDA Clearance for Phase I/II Trial of Cell Therapy for Familial Drusen

FDA Awards Dual Designations to Tikun's Novel Familial Dysautonomia Treatments

Homozygous Familial Hypercholesterolemia Treatment Market to Surge by 2034